Contents

Search


dichlorphenamide (Daranide)

Tradename: Daranide. Indications: - primary hypokalemic periodic paralysis - primary hyperkalemic periodic paralysis [2] Dosage: 50-100 mg PO BID Tabs: 50 mg. Drug interactions: - dichlorphenamide increases aspirin levels * anorexia, lethargy, tachypnea, coma when used in combination with aspirin [2]

Interactions

drug interactions drug adverse effects (more general classes) monitor with carbonic anhydrase inhibitors

General

carbonic anhydrase inhibitor sulfonamide

Properties

INHIBITS: carbonic anhydrase (dehydratase) MISC-INFO: elimination route LIVER KIDNEY

Database Correlations

PUBCHEM cid=3038

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Windle ML Rapid Rx Quiz: Headache Medications Medscape. Sept 12, 2022 https://reference.medscape.com/viewarticle/980181